Unlike conventional gene therapy, which struggles to deliver genes to the site of interest, CELLeBRAIN’s approach exploits the tumor-homing property of MSCs to facilitate gene delivery, maximizing both the efficiency and efficacy of our gene therapy.

Thanks to the proliferation capability of MSCs, CELLeBRAIN can easily scale production by orders of magnitude, creating a large quantity of homogeneous cells with the same therapeutic properties as the starting batch.